IRADIMED CORPORATION (IRMD) Operating Margin
- Operating margin · 12 months: Value 31.92%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 31.92% | Operating income / revenue. Period ending 2026-06-30. $27.55M ÷ $86.34M × 100 ≈ 31.92% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 27.55M USD | Operating Income (Loss) |
| Revenue | 86.34M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 3.09M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27.55M | $86.34M | (m) | $3.09M | (m) | 31.92% |
| 2026-03-31 | $27.95M | $86.28M | (m) | $3.31M | (m) | 32.40% |
| 2025-12-31 | $26.15M | $83.81M | (m) | $2.98M | (m) | 31.20% |
| 2025-09-30 | $24.85M | $80.51M | (m) | $2.75M | (m) | 30.87% |
| 2025-06-30 | $23.81M | $77.64M | (m) | $2.71M | (m) | 30.67% |
| 2025-03-31 | $22.65M | $75.15M | (m) | $2.63M | (m) | 30.13% |
| 2024-12-31 | $21.96M | $73.24M | (m) | $2.83M | (m) | 29.99% |
| 2024-09-30 | $21.32M | $71.31M | (m) | $2.91M | (m) | 29.91% |
| 2024-06-30 | $21.44M | $69.48M | (m) | $2.73M | (m) | 30.86% |
| 2024-03-31 | $20.78M | $67.69M | (m) | $3.69M | (m) | 30.70% |
| 2023-12-31 | $20.04M | $65.56M | (m) | $2.86M | (m) | 30.56% |
| 2023-09-30 | $19.13M | $62.97M | (m) | $2.81M | (m) | 30.38% |
| 2023-06-30 | $17.36M | $59.88M | (m) | $2.85M | (m) | 28.99% |
| 2023-03-31 | $16.56M | $56.47M | (m) | $2.55M | (m) | 29.33% |
| 2022-12-31 | $15.63M | $53.30M | (m) | $2.28M | (m) | 29.32% |
| 2022-09-30 | $14.48M | $50.31M | (m) | $2.17M | (m) | 28.79% |
| 2022-06-30 | $13.44M | $47.81M | (m) | $2.16M | (m) | 28.11% |
| 2022-03-31 | $11.12M | $44.90M | (m) | $1.95M | (m) | 24.76% |
| 2021-12-31 | $9.82M | $41.81M | (m) | $1.91M | (m) | 23.48% |
| 2021-09-30 | $7.36M | $38.49M | (m) | $1.92M | (m) | 19.12% |
| 2021-06-30 | $5.06M | $35.28M | (m) | $1.92M | (m) | 14.33% |
| 2021-03-31 | $283.68K | $32.26M | (m) | $1.95M | (m) | 0.88% |
| 2020-12-31 | $-756.09K | $31.72M | (m) | $1.90M | (m) | -2.38% |
| 2020-09-30 | $831.80K | $34.06M | (m) | $1.77M | (m) | 2.44% |
| 2020-06-30 | $2.57M | $36.33M | (m) | $1.66M | (m) | 7.06% |
| 2020-03-31 | $7.87M | $38.76M | (m) | $1.51M | (m) | 20.31% |
| 2019-12-31 | $8.65M | $38.52M | (m) | $1.43M | (m) | 22.45% |
| 2019-09-30 | $8.20M | $12.64M | (m) | $1.42M | (m) | 64.91% |
| 2019-06-30 | $7.13M | $10.29M | (m) | $1.43M | (m) | 69.32% |
| 2019-03-31 | $6.43M | $8.44M | (m) | $1.49M | (m) | 76.21% |
| 2018-12-31 | $6.00M | $30.44M | (m) | $1.52M | (m) | 19.72% |
| 2018-09-30 | $5.21M | $28.80M | (m) | $1.50M | (m) | 18.09% |
| 2018-06-30 | $3.96M | $26.88M | (m) | $1.51M | (m) | 14.73% |
| 2018-03-31 | $2.61M | $25.03M | (m) | $1.56M | (m) | 10.43% |
| 2017-12-31 | $1.29M | $23.08M | (m) | $1.72M | (m) | 5.57% |
| 2017-09-30 | $1.79M | $22.37M | (m) | $1.74M | (m) | 8.01% |
| 2017-06-30 | $4.19M | $24.35M | (m) | $1.81M | (m) | 17.20% |
| 2017-03-31 | $7.20M | $28.69M | (m) | $1.65M | (m) | 25.09% |
| 2016-12-31 | $10.92M | $32.50M | (m) | $1.35M | (m) | 33.60% |
| 2016-09-30 | $12.77M | $35.31M | (m) | $1.48M | (m) | 36.16% |
| 2016-06-30 | $13.38M | $35.83M | (m) | $1.54M | (m) | 37.34% |
| 2016-03-31 | $12.73M | $33.57M | (m) | $1.66M | (m) | 37.92% |
| 2015-12-31 | $11.51M | $31.59M | (m) | $1.76M | (m) | 36.44% |
| 2015-09-30 | $8.39M | $26.38M | (m) | $1.58M | (m) | 31.79% |
| 2015-06-30 | $5.59M | $22.00M | (m) | $1.36M | (m) | 25.41% |
| 2015-03-31 | $4.51M | $19.09M | (m) | $1.19M | (m) | 23.61% |
| 2014-12-31 | $3.07M | $15.65M | (m) | $1.07M | (m) | 19.59% |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $2.79M | $11.34M | (m) | $1.01M | (m) | 24.58% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |